NasdaqGS:MPLTBiotechs
A Look At MapLight Therapeutics (MPLT) Valuation After Its Sharp Recent Share Price Surge
MapLight Therapeutics (MPLT) has drawn attention after a sharp share price move over the past month, with the stock closing at US$30.05 and a market value around US$1.24b, inviting closer scrutiny from biotech investors.
See our latest analysis for MapLight Therapeutics.
The recent 76.6% 30 day share price return, and 79.2% year to date share price return, point to strong short term momentum that contrasts with MapLight Therapeutics’ early stage fundamentals and lack of reported revenue so...